Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Tremelimumab
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Tremelimumab Imjudo
®
(20 mg/ml concentrate for solution for infusion)
Malignant disease and immunosuppression, Other antineoplastic drugs, 08.01.05
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Tremelimumab
Tremelimumab [Specialist Drug]
Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Links found
NICE TA1090: Durvalumab with tremelimumab for untreated advanced or unresectable hepatocellular carcinoma